Detalles de la búsqueda
1.
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Haematologica
; 108(11): 3025-3032, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37102592
2.
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
Hematol Oncol
; 41(1): 39-49, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305717
3.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629030
4.
Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell Lymphoma.
Oncologist
; 26(9): e1660-e1663, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097758
5.
Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma.
Oncologist
; 26(11): e2079-e2081, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34227176
6.
Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
Curr Oncol Rep
; 21(9): 84, 2019 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410582
7.
Management of post-transplant lymphoproliferative disorders.
Br J Haematol
; 182(3): 330-343, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741774
8.
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Blood Adv
; 7(23): 7295-7303, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729621
9.
Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis.
Blood Adv
; 6(24): 6180-6186, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36170803
10.
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
Blood Cancer J
; 12(5): 78, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504884
11.
Future directions in Hodgkin lymphoma: checkpoint inhibitors and beyond.
Leuk Lymphoma
; 62(8): 1795-1804, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602008
12.
Artificial intelligence in inflammatory bowel disease endoscopy: current landscape and the road ahead.
Ther Adv Gastrointest Endosc
; 14: 26317745211017809, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34345816
13.
Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(2): e185-e193, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132102
14.
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
Blood Cancer J
; 11(9): 160, 2021 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34564694
15.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Leuk Lymphoma
; 62(8): 1816-1827, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653216
16.
Lymphoma survivors have an increased long-term risk of chronic kidney disease.
Leuk Lymphoma
; 61(12): 2923-2930, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654590
17.
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
Leuk Lymphoma
; 61(10): 2375-2382, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32508208
Resultados
1 -
17
de 17
1
Próxima >
>>